Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 80
- Press releases
#ReleaseMyMeds Campaign Launches to Protect the Rights of Patients to Access Their Medicine
Release is launching a vital initiative. We are launching the #ReleaseMyMeds campaign to protect the rights of patients to access their medicine.
- Adult-Use
This Is The ‘Last 4/20 That Cannabis Will Be Schedule I’ Drug Says Blumenauer, As He Pushes Its Election Importance
US Rep. Earl Blumenauer, founding co-chair of the Congressional Cannabis Caucus, said he believes Saturday was the ‘last 4/20 celebration that cannabis will be on Schedule I’.
- Uncategorized
New York’s Illicit Cannabis Market Could Finally Be Brought Down As Sweeping New Powers Introduced
New York’s Governor Kathy Hochul has announced a new plan to ‘finally put an end to the chaos’ of unlicensed shops throughout the state.
- CBD Market
Jersey Hemp Wins Watershed Legal Battle Against UK Home Office Which Threatened Entire CBD Industry
Jersey Hemp has won a watershed court battle against the UK Home Office, which has now admitted acting unlawfully in banning the CBD company from importing products to the UK.
- Uncategorized
Cannabis Criminalization ‘Does Little To Curtail Use’ New Poll Finds
Cannabis criminalization ‘does little to curtail use’ according to a new study, which found only a 1.1% difference in regular cannabis usage between states where cannabis is legal and where it is not.
- Uncategorized
Kentuckians Will Have Access To Medical Cannabis This Year
Kentucky citizens could now have access to medical cannabis this year as the state’s Governor Andy Beshear announced plans to significantly reduce the timeline.
- Hemp Industry
US Hemp Production Saw Near 20% Increase In 2023
Hemp production in the US rose by nearly 20% last year, following a difficult 2022 for the industry, which experienced a significant decline.
- Markets & Stocks
OCT Announces 2nd Clinical Trial, Chill Brands Investor Calls For Director Ousting, & More From SEED
Oxford Cannabinoid Technologies [stock_market_widget type=”chart” template=”line” assets=”OCTP.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Oxford Cannabinoid Technologies (OCT) has announced plans to launch a Phase 1 clinical trial into a second compound after partnering with Australian contract research organisation (CRO) iNGENū.
- Uncategorized
Hopes Of Tax Relief For Canadian Cannabis Industry Dashed As Budget Reveals No Changes
Hopes of tax relief for Canada’s cannabis industry were derailed yesterday as the country’s Federal Budget 2024 revealed excise taxes would not be changed.
- Hemp Industry
UK Home Office Overhauls Hemp Licensing Framework In ‘Game Changing’ Move For Farmers
Last week, the UK Home Office announced some significant changes to its licensing framework for the country’s industrial hemp industry.
- Uncategorized
Cannabis Rescheduling Review ‘Now With The DOJ’ Says White House Press Secretary
The White House Press Secretary, Karine Jean-Pierre, has suggested that the Department of Justice could now have the final say in whether cannabis is rescheduled.
- Uncategorized
Colorado Cannabis Sales Fall Again In February, As Industry Struggles To Offset Decline
Colorado’s cannabis sales have fallen for a second consecutive month, as the state’s cannabis market continues its decline.











